Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 5 (2008), Issue 10 (October)

1. Sirtuins--novel therapeutic targets to treat age-associated diseases.
   Nat Rev Drug Discov, 7(10): 841-53. [Abstract] [Full-text]
2. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes.
   FASEB J, 22(10): 3581-94. [Abstract] [Full-text]
3. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema.
   Invest Ophthalmol Vis Sci, 49(10): 4290-6. [Abstract] [Full-text]
4. Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetes.
   Invest Ophthalmol Vis Sci, 49(10): 4219-25. [Abstract] [Full-text]
5. Continuous glucose monitoring and intensive treatment of type 1 diabetes.
   N Engl J Med, 359(14): 1464-76. [Abstract] [Full-text]
6. A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes.
   Health Qual Life Outcomes, 6: 71. [Abstract] [Full-text]
7. Evaluation of Bensal HP for the treatment of diabetic foot ulcers.
   Adv Skin Wound Care, 21(10): 461-5. [Abstract] [Full-text]
8. Sustained reduction in major amputations in diabetic patients: 628 amputations in 461 patients in a defined population over a 20-year period.
   Acta Orthop, 79(5): 665-73. [Abstract] [Full-text]
9. Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up study.
   BMC Health Serv Res, 8: 189. [Abstract] [Full-text]
10. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
    Diabetologia, 51(11): 2126-33. [Abstract] [Full-text]
11. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century.
    Diabetologia, 51(11): 1971-9. [Abstract] [Full-text]
12. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus.
    Diabetologia, 51(11): 2088-92. [Abstract] [Full-text]
13. Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.
    Diabetologia, 51(11): 1998-2002. [Abstract] [Full-text]
14. Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type 1 diabetes mellitus: a randomised controlled trial.
    Diabetologia, 51(11): 2049-59. [Abstract] [Full-text]
15. Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes.
    Diabetologia, 51(11): 2031-40. [Abstract] [Full-text]
16. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial.
    Diabetologia, 51(11): 1954-61. [Abstract] [Full-text]
17. Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.
    Diabetologia, 51(11): 2068-77. [Abstract] [Full-text]
18. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Diabetologia, 51(11): 2100-7. [Abstract] [Full-text]
19. Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles.
    Diabetologia, 51(11): 1989-92. [Abstract] [Full-text]
20. Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement.
    Diabetologia, 51(11): 1962-70. [Abstract] [Full-text]
21. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population.
    Diabetologia, 51(11): 1993-7. [Abstract] [Full-text]
22. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.
    Diabetologia, 51(11): 1937-46. [Abstract] [Full-text]
23. Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: the Whitehall II study.
    Br J Nutr, 100(5): 1046-53. [Abstract] [Full-text]
24. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
    N Engl J Med, 359(15): 1565-76. [Abstract] [Full-text]
25. 10-year follow-up of intensive glucose control in type 2 diabetes.
    N Engl J Med, 359(15): 1577-89. [Abstract] [Full-text]
26. Sequence variants in the PLEKHH2 region are associated with diabetic nephropathy in the GoKinD study population.
    Hum Genet, 124(3): 255-62. [Abstract] [Full-text]
27. Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004.
    Arch Ophthalmol, 126(10): 1421-7. [Abstract] [Full-text]
28. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Arch Intern Med, 168(18): 1975-83. [Abstract] [Full-text]
29. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Circulation, 118(16): 1626-36. [Abstract] [Full-text]
30. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.
    BMC Public Health, 8: 350. [Abstract] [Full-text]
31. Association of ADIPOR2 with liver function tests in type 2 diabetic subjects.
    Obesity (Silver Spring), 16(10): 2308-13. [Abstract] [Full-text]
32. Ordered stratification to reduce heterogeneity in linkage to diabetes-related quantitative traits.
    Obesity (Silver Spring), 16(10): 2314-22. [Abstract] [Full-text]
33. Psychiatric and cardiovascular comorbidities in patients with diabetes mellitus starting antiobesity drugs.
    Obesity (Silver Spring), 16(10): 2331-5. [Abstract] [Full-text]
34. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Am J Gastroenterol, 103(10): 2481-7. [Abstract] [Full-text]
35. Relation between the level of American Indian and Alaska Native diabetes education program services and quality-of-care indicators.
    Am J Public Health, 98(11): 2079-84. [Abstract] [Full-text]
36. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.
    J Hypertens, 26(11): 2198-206. [Abstract] [Full-text]
37. The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
    J Hypertens, 26(11): 2103-11. [Abstract] [Full-text]
38. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients.
    Ophthalmology, 115(10): 1818-25. [Abstract] [Full-text]
39. The influence of diabetes mellitus type 1 and 2 on the thickness, shape, and equivalent refractive index of the human crystalline lens.
    Ophthalmology, 115(10): 1679-86. [Abstract] [Full-text]
40. Heart rate response to adenosine in patients with diabetes mellitus and normal myocardial perfusion imaging.
    Am J Cardiol, 102(8): 1103-6. [Abstract] [Full-text]
41. Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: a prospective study in 716 patients over 8 years.
    BMC Cardiovasc Disord, 8: 27. [Abstract] [Full-text]
42. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.
    Cardiovasc Diabetol, 7: 29. [Abstract] [Full-text]
43. Relationships between vascular indexes and atherosclerotic risk factors in patients with type 2 diabetes mellitus.
    Angiology, 59(5): 567-73. [Abstract] [Full-text]
44. The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women.
    Hum Mol Genet, 17(22): 3502-8. [Abstract] [Full-text]
45. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.
    Lancet, 372(9647): 1385-93. [Abstract] [Full-text]
46. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
    Lancet, 372(9647): 1394-402. [Abstract] [Full-text]
47. Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice.
    Clin Immunol, 129(2): 195-201. [Abstract] [Full-text]
48. The validity and reliability of automated and manually measured toe blood pressure in ischemic legs of diabetic patients.
    Eur J Vasc Endovasc Surg, 36(5): 576-81. [Abstract] [Full-text]
49. Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
    Nature, 455(7216): 1109-13. [Abstract] [Full-text]
50. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
    Med Care, 46(11): 1125-33. [Abstract] [Full-text]
51. The comorbidity of diabetes mellitus and depression.
    Am J Med, 121(11): S8-15. [Abstract] [Full-text]
52. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.
    J Am Soc Nephrol, 19(11): 2077-85. [Abstract] [Full-text]
53. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
    J Am Soc Nephrol, 19(11): 2098-107. [Abstract] [Full-text]
54. Do guidelines for the diagnosis and monitoring of diabetes mellitus fulfill the criteria of evidence-based guideline development?
    Clin Chem, 54(11): 1872-82. [Abstract] [Full-text]
55. Are the adverse effects of glitazones linked to induced testosterone deficiency?
    Cardiovasc Diabetol, 7: 30. [Abstract] [Full-text]
56. GAD treatment and insulin secretion in recent-onset type 1 diabetes.
    N Engl J Med, 359(18): 1909-20. [Abstract] [Full-text]
57. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects.
    J Vasc Surg, 48(5): 1197-203. [Abstract] [Full-text]
58. Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.
    Eur J Clin Pharmacol, 64(11): 1093-100. [Abstract] [Full-text]
59. Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
    Invest Ophthalmol Vis Sci, 49(11): 4707-11. [Abstract] [Full-text]
60. Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation.
    Invest Ophthalmol Vis Sci, 49(11): 5089-93. [Abstract] [Full-text]
61. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.
    Invest Ophthalmol Vis Sci, 49(11): 4746-52. [Abstract] [Full-text]
62. A severity scale for diabetic macular edema developed from ETDRS data.
    Invest Ophthalmol Vis Sci, 49(11): 5041-7. [Abstract] [Full-text]
63. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes.
    FASEB J, 22(11): 3947-55. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.